Effects of soy germ isoflavones and hormone therapy on nitric oxide derivatives, low-density lipoprotein oxidation, and vascular reactivity in hypercholesterolemic postmenopausal women

Menopause

Volumn 13, Issue 6, 2006, Pages 942-950

  Pereira, Isabela R O ^a   Faludi, André Arpad ^b   Aldrighi, José Mendes ^a   Bertolami, Marcelo Chiara ^b   Saleh, Mohamed H ^b   Silva, Renata Alves ^b   Nakamura, Yara ^b   Campos, Maria Fernanda ^a   Novaes, Nadjara ^a   Abdalla, Dulcineia Saes Parra ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Cholesterol oxides; Electronegative low density lipoprotein; Isoflavones; Nitric oxide; Soy germ; Vascular reactivity

Indexed keywords

3 NITROTYROSINE; CHOLESTEROL DERIVATIVE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ISOFLAVONE; LOW DENSITY LIPOPROTEIN; NITRATE; NITRIC OXIDE; NITRITE; S NITROSOTHIOL;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATION; POSTMENOPAUSE; SOYBEAN; STATISTICAL SIGNIFICANCE;

EID: 33751056013     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000248703.22581.8a     Document Type: Article

References (47)

1. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002;89(12A):12E-17E.
2. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
3. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
4. Anderson GL, Limacher M, Assaf AR, et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in post-menopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
5. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263.
6. Lancaster JJR. Nitric Oxide: Principles and Actions. San Diego, CA: Academic Press, 1996.
7. Beckman JS, Ye YZ, Anderson PG, et al. Extensive nitration of phenolics by peroxinitrite. Arch Biochem Biophys 1992;288:438-444.
8. Darley-Usmar VM, Hogg N, O'Leary VJ, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 1992;17:9-20.
9. Dewitt DS, Mathew BP, Chaisson JM, Prough DS. Peroxynitrite reduces vasodilatory responses to reduced intravascular pressure, calcitonin gene-related peptide, and cromakalim in isolated middle cerebral arteries. J Cereb Blood Flow Metab 2001;21:253-261.
10. Van Der Loo B, Labugger R, Skepper JN, et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000;192:1731-1744.
11. Strunk V, Hahnenkamp K, Schneuing M, Fischer LG, Rich GF. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation. Anesth Analg 2001;92:681-687.
12. Dekert V, Persegol L, Viens L, et al. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium- dependent relaxation. Circulation 1997;95:723-731.
13. Vaya J, Aviram M, Mahmood S, et al. Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res 2001;34:485-497.
14. Murphy PR, Breckenridge WC, Lazier CB. Binding of oxygenated cholesterol metabolites to antiestrogen binding sites from chicken liver. Biochem Biophys Res Commun 1985;127:786-792.
15. Hwang PL, Matin A. Interactions of sterols with antiestrogen-binding sites: structural requirements for high-affinity binding. J Lipid Res 1989;30:239-245.
16. Avogaro P, Cazzolato G, Bittolo-Bom G. Some questions concerning a small, more electronegative LDL circulating in human plasma. Atherosclerosis 1991;91:163-171.
17. Benitez S, Ordonez-Llanos J. Electronegative low-density lipoprotein. Curr Opin Lipidol 2004;15:329-335.
18. Faludi AA, Aldrighi JM, Bertolami MC, et al. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis 2004;177:89-96.
19. Pereira IRO, Abdalla DSP. Soy isoflavones reduce heat shock proteins in experimental atherosclerosis. Eur J Nutr 2006;45:178-186.
20. Pereira IR, Bertolami MC, Faludi AA, et al. Lipid peroxidation and nitric oxide inactivation in post-menopausal women. Arq Bras Cardiol 2003;80:406-423.
21. Pereira EC, Bertolami MC, Faludi AA, Sevanian A, Abdalla DS. Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients. Free Radic Biol Med 2004;37:1440-1448.
22. Squadrito F, Altavilla D, Morabito N, et al. The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in post-menopausal women. Atherosclerosis 2002;163:339-347.
23. Squadrito F, Altavilla D, Crisafulli A, et al. Effect of genistein on endothelial function in post-menopausal women: a randomized, double-blind, controlled study. Am J Med 2003;114:470-476.
24. Anthony MS, Clarkson TB, Hugles CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 1996;126:43-50.
25. Crouse JR, Morgan TM, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999;159:2070-2076.
26. Greaves KA, Wilson MD, Rudel LL, Williams JK, Wagner JD. Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr 1999;129:1585-1592.
27. Nestel PJ, Yamashita T, Sasahara T, Pomeroy S, Dart A, Komesaroff P. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997;17:3392-3398.
28. Fuhrman B, Buch S, Vaya J, et al. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein. Am J Clin Nutr 1997;66:267-275.
29. Hwang J, Wang J, Morazzoni P, Hodis HN, Sevanian A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification. Free Radic Biol Med 2003;34:1271-1282.
30. Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:195-201.
31. Atkinson C, Warren RM, Sala E, et al. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Cancer Res 2004;6:R170-R179.
32. Barbacanne MA, Rami J, Michel JB, et al. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res 1999;41:672-681.
33. Hayashi T, Yamada K, Esaki T, Mutoh E, Iguchi A. Effect of estrogen on isoforms of nitric oxide synthase: possible mechanism of anti-atherosclerotic effect of estrogen. Gerontology 1997;43:24-34.
34. Yen GC, Lai HH. Inhibition of reactive nitrogen species effects in vitro and in vivo by isoflavones and soy-based food extracts. J Agric Food Chem 2003;51:7892-7900.
35. Lahde M, Korhonen R, Moilanen E. Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor-kappa B-dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin. Aliment Pharmacol Ther 2000;14:945-954.
36. Yen GC, Lai HH. Inhibitory effects of isoflavones on nitric oxideor peroxynitrite-mediated DNA damage in RAW 264.7 cells and X174 DNA. Food Chem Toxicol 2003;40:1433-1440.
37. Wang J, Green PS, Simpkins JW. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem 2001;77:804-811.
38. Eiserich JP, Patel RP, O'Donnell VB. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 1998;19:221-357.
39. Ayres S, Tang M, Subbiah MT. Estradiol-17β as an antioxidant: some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med 1996;128:367-375.
40. Salonen JT, Nyyssonen K, Salonen R, et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 1997;95:840-845.
41. Sevanian A, Hodis HN, Hwang J, Mcleod LL, Peterson H. Cholesterol oxidation products induce vascular foam cell lesion formation in hypercholesterolemic New Zealand white rabbits. Arterioscler Thromb Vasc Biol 1999;19:2179-2188.
42. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A 1998;95:3106-3110.
43. Ashton EL, Dalais FS, Ball MJ. Effect of meat replacement by tofu on CHD risk factors including copper induced LDL oxidation. J Am Coll Nutr 2000;19:761-767.
44. Yamakoshi J, Piskula MK, Izumi T, et al. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J Nutr 2000;130:1887-1893.
45. Hale G, Paul-Labrador M, Dwyer JH, Merz CN. Isoflavone supplementation and endothelial function in menopausal women. Clin Endocrinol 2002;56:693-701.
46. Colacurci N, Chiantera A, Fornaro F, et al. Effects of soy isoflavones on endothelial function in healthy post-menopausal women. Menopause 2005;12:299-307.
47. Lissin LW, Oka R, Lakshmi S, Cooke JP. Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc Med 2004;9:26-30.